News
Foundation helping fund cancer research
The Kate Amato Foun- dation (KAF) is continu- ing to honor Childhood Cancer Awareness Month this September with two announcements. They are awarding $75,000 to fund two pediatric cancer research projects, which serves the organization’s mission. The organization has also launched Kate’s Kindness Project, which provides immediate direct support to local children hospitalized with cancer.
Kate Amato Foundation awards $75,000 in grants for pediatric cancer research
The Kate Amato Foundation continues to honor Childhood Cancer Awareness Month this September with two exciting announcements. The foundation has awarded $75,000 to fund two groundbreaking pediatric cancer research projects. The group has also launched Kate’s Kindness Project, which provides immediate direct support to local children hospitalized with cancer.
Childhood Cancer Research Team at Nationwide Children’s Hospital Awarded $10.2 Million Moonshot Grant
COLUMBUS, Ohio – The National Cancer Institute at the National Institutes of Health announced it has awarded one of its Cancer Moonshot grants to Timothy Cripe, MD, PhD, chief of the division of Hematology, Oncology & Blood and Marrow Transplant and Elaine Mardis, PhD, co-executive director of the Steve and Cindy Rasmussen Institute for Genomic Medicine at Nationwide Children’s Hospital.
FDA Approves First Gene Therapy For Leukemia
The Food and Drug Administration on Wednesday announced what the agency calls a “historic action” — the first approval of a cell-based gene therapy in the United States.
Anti-inflammatory strategy could lead to improved survival of children with neuroblastoma
Researchers at Karolinska Institutet and Karolinska University Hospital have discovered that an anti-inflammatory drug candidate inhibiting the prostaglandin E2 producing enzyme mPGES-1 in the tumor stroma reduces tumor growth in experimental neuroblastoma models. The findings are published in EBioMedicine and open for new treatment strategies for this aggressive childhood cancer.
Seattle Children’s Opens First CAR T-Cell Immunotherapy Trial in the U.S.
Seattle Children’s has opened the first chimeric antigen receptor (CAR) T-cell immunotherapy trial in the U.S. for children and young adults with relapsed or refractory CD19- and CD22-positive acute lymphoblastic leukemia (ALL) that will simultaneously attack two targets on cancer cells.
A medical breakthrough that hacks genes to fight cancer just got approved
The Food and Drug Administration on Wednesday approved the first-ever gene therapy in the US.
FDA approval brings first gene therapy to the United States
CAR T-cell therapy approved to treat certain children and young adults with B-cell acute lymphoblastic leukemia.
FDA Panel Backs Groundbreaking Novartis Treatment
A panel of experts which advises the FDA has unanimously voted to recommend approval of a pioneering cancer therapy from Novartis.
